MENU
+Compare
BIO
Stock ticker: NYSE
AS OF
Sep 12 closing price
Price
$280.34
Change
-$5.56 (-1.94%)
Capitalization
7.47B

BIO Bio-Rad Laboratories IncClass A Forecast, Technical & Fundamental Analysis

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets... Show more

BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BIO with price predictions
Sep 12, 2025

BIO sees MACD Histogram crosses below signal line

BIO saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 02, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 55 instances where the indicator turned negative. In of the 55 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for BIO moved out of overbought territory on August 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BIO as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BIO advanced for three days, in of 342 cases, the price rose further within the following month. The odds of a continued upward trend are .

BIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 203 cases where BIO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BIO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.064) is normal, around the industry mean (59.934). P/E Ratio (25.279) is within average values for comparable stocks, (37.822). BIO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.622). BIO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (3.049) is also within normal values, averaging (79.677).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BIO is expected to report earnings to fall 24.52% to $1.97 per share on October 23

Bio-Rad Laboratories IncClass A BIO Stock Earnings Reports
Q3'25
Est.
$1.97
Q2'25
Beat
by $0.88
Q1'25
Beat
by $0.74
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.85
The last earnings report on July 31 showed earnings per share of $2.61, beating the estimate of $1.73. With 242.38K shares outstanding, the current market capitalization sits at 7.47B.
A.I. Advisor
published General Information

General Information

a manufacturer of life science research products and clinical diagnostics

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1000 Alfred Nobel Drive
Phone
+1 510 724-7000
Employees
8030
Web
https://www.bio-rad.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GSG22.760.09
+0.40%
iShares S&P GSCI Commodity-Indexed Trust
EVSB51.030.02
+0.04%
Eaton Vance Ultra-Short Income ETF
CADRUB61.08N/A
N/A
Canadian Dollar - Russia Ruble
HFSP17.88N/A
N/A
TradersAI Large Cap Equity & Cash ETF
DYFI23.37-0.01
-0.06%
IDX Dynamic Fixed Income ETF

BIO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BIO has been closely correlated with A. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
-1.94%
A - BIO
71%
Closely correlated
-2.75%
DHR - BIO
69%
Closely correlated
-2.62%
TMO - BIO
68%
Closely correlated
-2.43%
MTD - BIO
66%
Closely correlated
-1.81%
ILMN - BIO
64%
Loosely correlated
-4.22%
More

Groups containing BIO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
-1.94%
BIO
(6 stocks)
73%
Closely correlated
-2.47%
Medical/Nursing Services
(226 stocks)
51%
Loosely correlated
+0.03%
Health Services
(438 stocks)
33%
Poorly correlated
-0.10%